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ABSTRACT
Objective: To examine the long-term impact of health counselling among middle-aged men at
high risk of CVD.
Design: An observational study with a 5-year follow-up.
Setting and intervention: All men aged 40 years in Helsinki have been invited to a visit to
evaluate CVD risk from 2006 onwards. A modified version of the North Karelia project risk tool
(CVD risk score) served to assess the risk. High-risk men received lifestyle counselling based on
their individual risk profile in 2006 and were invited to a follow-up visit in 2011.
Subjects: Of the 389 originally high-risk men, 159 participated in the follow-up visits in 2011.
Based on their follow-up in relation the further risk communication, we divided the participants
into three groups: primary health care, occupational health care and no control visits.
Main outcome measures: Lifestyle and CVD risk score change.
Results: All groups showed improvements in lifestyles. The CVD risk score decreased the most
in the group that continued the risk communication visits in their primary health care
centre (6.1 to 4.8 [95% CI 1.6 to 0.6]) compared to those who continued risk communication
visits in their occupational health care (6.0 to 5.4 [95% CI 1.3 to 0.3]), and to those with no risk
communication visits (6.0 to 5.9 [95% CI 0.5 to 0.4]).
Conclusions: These findings indicate that individualized lifestyle counselling improves health
behaviour and reduces total CVD risk among middle-aged men at high risk of CVD. Sustained
improvement in risk factor status requires ongoing risk communication with health care
providers.
KEY POINTS
 Studies of short duration have shown that lifestyle changes reduce the risk of cardiovascular
disease among high-risk individuals.
 Sustaining these lifestyle changes and maintaining the lower disease risk attained can prove
challenging.
 Cardiovascular disease (CVD) risk assessment and individualized health counselling for high-
risk men, when implemented in primary health care, have the potential to initiate lifestyle
changes that support risk reduction.
 Attaining a sustainable reduction in CVD risk requires a willingness to engage in risk-related
communication from both health care providers and the individual at high risk.
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Cardiovascular disease (CVD) remains the dominant
non-communicable disease cluster in the twenty-
first century. Each year CVD accounts for over four
million deaths in Europe, representing 46% of all
deaths in Europe.[1] Predisposing risk factors for all
manifestation of CVD are unhealthy lifestyles that
include: smoking, non-optimal dietary habits, physical
inactivity and overweight. Consequences often include
unwanted changes in cardio-metabolic risk factors
such as dyslipidemia, hyperglycaemia and elevated
blood pressure. However, all of these risk factors are
modifiable through lifestyle changes. Evidence from
randomized controlled trials shows the positive
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influences of lifestyle counselling on risk factors for
CVD among high-risk subjects. In studies of short
duration, follow-up in primary health care [2–4] and
in occupational health care [5,6] that compared inten-
sive lifestyle support with usual care successfully
reduced risk. A non-randomized controlled commu-
nity-based study that compared intensive lifestyle and
usual care groups yielded a similar result, as outcome
measurement took place at 18 months after base-
line.[7] However, the existing literature did not always
support the effectiveness of lifestyle counselling as
shown in short-term [8] and long-term randomized
trials.[9] On the other hand, long-term prospective
cohort studies have shown healthier life styles to
associate with lower incidences of myocardial infarc-
tion [10] and CVD mortality.[11] We conducted a pro-
spective follow-up study of middle-aged men at high
risk of CVD. The study had three different aims: to
evaluate the influence of individualized risk assess-
ment and lifestyle counselling on participant’s life-
style, on cardio-metabolic risk factors, and on total
CVD risk during a 5-year follow-up, the results of
which will be presented here.
Methods
Subjects and study design
Traditionally, primary prevention is one main task in
primary health care, but to provide lifestyle interven-
tion during a normal visit is often considered a chal-
lenge. To provide systematic preventive measures to
high-risk men in the Helsinki area, the City of Helsinki
and the Helsinki Heart District (a member of the
Finnish Heart Association) launched this project as well
as trained the study nurses and developed the tools
used for guidance.
Every year since 2006, all men aged 40 years living
in Helsinki have been invited to visit their local health
care centre for an evaluation of their CVD risk and, if
warranted, to receive health counselling. Of the 4274
men invited to such a visit in 2006, 1454 (34%) partici-
pated. During the appointment, a trained nurse inter-
viewed the participants about their lifestyle. A
modified version of the North Karelia project risk tool
(CVD risk score) served to assess CVD risk.[12]
Altogether 471 men with a CVD risk score of 4.5
received lifestyle counselling based upon their own
individual risk profile in accordance with national
Finnish guidelines for preventing CVD, which are
based upon the European guidelines for CVD preven-
tion in clinical practice.[13] Printed health education
materials addressing health behaviour, physical activ-
ity, smoking cessation and dietary habits supple-
mented the personal lifestyle counselling. When
appropriate, the men were invited to participate in
regular group sessions for weight control or smoking
cessation at their local health care centres. Blood pres-
sure, blood lipids or blood sugar levels exceeding the
guidelines’ cut-off points triggered a referral to a phys-
ician for further evaluation. All high-risk men were
advised to meet with their health care providers for
CVD risk monitoring every 1–2 years. In other words,
high-risk men meet with health care professionals for
CVD risk monitoring according to their own motiv-
ation. Their local health care centres provided long-
term follow-up as normal day-to-day practice or they
visited their occupational health services or used pri-
vate health care services. We designed a follow-up
study protocol for these men at higher risk. The Ethics
Committee at Helsinki University Central Hospital
approved the protocol. According to the study proto-
col, the high-risk men will be invited to a re-evaluation
visit after 2 and 5 years. The results from the 2-year
follow-up have been published previously.[14] In 2011,
we identified and invited a total of 389 originally high-
risk men for a re-evaluation visit. Of these, 159 men
provided their written informed consent and partici-
pated in the lifestyle interview, the same risk assess-
ment, and measurements as during the baseline visit
in 2006. In addition, each participant’s contacts with
health care providers after the baseline visit were
recorded, in order to assess potential differences
between primary health care, occupational health care,
and private health care, in managing their CVD risk.
Measurements
We used the mean of two blood pressure measure-
ments obtained with the subject in the sitting position
using an automated sphygmomanometer (Omron
HEM-7051-E, Kyoto, Japan). We measured height (with-
out shoes) to the nearest 0.1 cm, and weight was
measured with the participants wearing light indoor
clothing to the nearest 0.1 kg; we calculated BMI as
kg/m2. We measured waist circumference midway
between the lowest rib and the iliac crest was meas-
ured with the participants in a standing position. We
made all measurements according to standard techni-
ques. A trained technician drew blood samples after
an overnight fast and had them analysed for lipids
and glucose in a certified central laboratory.
CVD risk assessment
The CVD risk score, a modified version of the North
Karelia project risk tool, is based on BMI, smoking,
physical activity, systolic and diastolic blood pressure
and total cholesterol concentration (Table 1).
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Depending on risk factor status, a subject’s risk score
can range from 0 to 16. A subject with a score of at
least 4.5 points is categorised as high risk. We also
assessed subjects’ 10-year risk of fatal CVD risk
extrapolated to age 60 with the Score European Low
Risk Chart. The Score Chart is based on gender, age,
systolic blood pressure, total cholesterol and smoking
status.[13]
Statistics
Clinical characteristics and risk scores: We used one-way
analysis of variance (ANOVA) to analyse between-
group differences in clinical characteristics and risk
scores at baseline and follow-up, and paired samples t-
test for within-group analysis. To compare of changes
between the groups, we applied the Univariate
General Linear model. PASW/SPSS software served in
the above analysis. Lifestyle characteristics: The
Freeman-Halton extension of Fisher’s exact test (www.
vassarstats.net/fisher2x3.html) served to analyse pro-
portions between groups. Changes between groups
were analysed with PASW/SPSS software’s Binary
Logistic Regression model. We performed within-group
analysis with Wilson’s method for paired samples pro-
portions and their differences using Confidence
Intervals Analysis (CIA) software for Windows. We used
PASW statistics for Windows, version 20.0 (SPSS Inc.,
Chicago, IL).
Results
The number of dropouts during the 5-year follow-up
was 230. At baseline, we found no differences between
the dropouts and those who continued in any of the
risk factors assessed (all p> .11). However, the two
groups showed differences in lifestyle factors at base-
line: rate of smoking 64.5% vs. 55.3% (p¼ .070), physical
activity 38.8% vs. 28.9% (p¼ .046), and use of soft fats
28.4% vs. 18.9% (p¼ .023); dropouts presented first.
The CVD risk score was higher in the dropouts than in
those who continued (6.4 vs. 6.1, p¼ .046). The mean
follow-up time was 5.1 years (SD ¼0.4). Among all par-
ticipants (n¼ 159), the mean CVD risk score decreased
from 6.1 at baseline to 5.4 at the final visit (p< .001);
the Score risk chart extrapolated to age 60 decreased
from 4.9 to 4.5 (p¼ .060). We grouped the participants
into three groups according of their choice on where to
continue their risk communication. Of the participants;
34.6% (Group 1) had visited no health care providers
for CVD risk monitoring between baseline and follow-
up, 37.1% had made such visits at their primary health
care centres (Group 2), and 28.3% had visited at their
occupational health care centres (Group 3). Only two
men were followed up in private health care centres,
for further analyses, we included these men in Group 3.
Of the 12 participants who participated in weight-con-
trolling sessions, 7 belonged to Group 2 and 5 to Group
3; only one participants (Group 3) took part in smoking
cessation sessions organised regularly at their local
health care centres during the follow-up period. A posi-
tive family history for CVD was reported by 18.5% of
the men in Group 1, 45.5% of the men in Group 2, and
40.3% of the men in Group 3. At baseline none of the
participants received antihypertensive, lipid-lowering or
diabetes medication. During follow-up, however, men
in Groups 2 and 3 began receiving medications as fol-
lows: antihypertensive medication for 40.7% and 26.7%
(p¼ .136), respectively, lipid lowering medication for
23.7% and 8.9% (p¼ .048), respectively, and diabetes
medication for 10.2% and 2.2% (p¼ .110), respectively.
The clinical characteristics of the study population
appear in Table 2. At baseline, the groups showed no
significant differences in clinical characteristics other
than diastolic blood pressure. At follow-up, the groups
showed no significant differences in any of the assessed
clinical characteristics. However, we did identify statis-
tically significant changes within groups (Table 2). BMI
increased in Group 3, systolic and diastolic blood
Table 1. CVD risk score according to modified method of North Karelia project risk score.
Score BMIa, kg/m2 Current smoking Physical activityd Systolic BPb, mmHg Diastolic BPb, mmHg Total-Cc, mmol/L
0 24.9 0 3x/week 129 79 4.9
0.5 25–26.9 Occasionally 1–2x/week 130–139 80–89 5.0–5.4
1.0 27–28.9 1–4/day App. 1x/week 140–149 90–94 5.5–5.9
1.5 29–30.9 5–9/day Sometimes 150–159 95–99 6.0–6.4
2.0 31 10–14/day Never 160 100 6.5–6.9
2.5 – 15–19/day – – – 7.0–7.4
3.0 – 20–24/day – – – 7.5–7.9
3.5 – 25–29/day – – – 8.0–8.4
4.0 – 30/day – – – 8.5
aBMI: body mass index;
bBP: blood pressure;
cTotal-C: total cholesterol.
dContinuous physical activity (duration at least 30min) causing sweating or some shortness of breath.
According to used criteria, high-risk persons have the risk score of 4.5.
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pressures increased in Group 1, diastolic blood pressure
decreased in Group 2, total cholesterol concentration
increased in Group 1, LDL cholesterol concentrations
decreased in Group 2, HDL cholesterol decreased in all
three groups, and glucose concentration increased in
Groups 1 and 3. The changes in systolic (p¼ .004) and
diastolic blood pressure (p¼ .003), as well as in total
(p¼ .029) and LDL cholesterol (p¼ .031) differed signifi-
cantly between the groups. The lifestyle factors
assessed either at baseline or at follow-up visit showed
no difference between groups (Table 3). During the
follow-up smoking decreased significantly in Groups 1
and 2, and physical activity increased statistically signifi-
cantly in all groups, as did percentage of users of soft
fats. Risk scores at baseline and changes during the fol-
low-up appear in Table 4. At baseline, means in either
the CVD risk score (p¼ .898) or Score Chart (p¼ .594)
showed no significant differences, whereas at follow-
up, they did CVD risk score (p¼ .027) and Score Chart
(p¼ .010). The CVD risk score decreased most in Group
2 during follow-up, only in Group 2 was the change
statistically significant. The Score Chart decreased in
Table 2. Clinical characteristic at baseline and 5-year follow-up grouped according to CVD risk control visits.
CVD risk control visits during follow-up
No control Primary care Occupational care All
n¼ 55 n¼ 59 n¼ 45 p Valuea n¼ 159 p Valueb
BMI (kg/m2)
Baseline 29.1 (4.5) 30.2 (6.6) 29.0 (4.3) 0.434 29.5 (5.3) –
Follow-up 29.7 (4.5) 30.6 (7.2) 29.9 (4.6) 0.650 30.1 (5.7) –
Change 0.6 (2.3) 0.4 (2.4) 0.9 (2.1) 0.692 0.6 (2.3) .001
95% CI 0.4 to 1.2 0.2 to 1.1 0.3 to 1.5 – 0.3 to 1.0 –
WC (cm)
Baseline 101.7 (12.0) 105.9 (15.3) 103.1 (10.8) 0.244 103.7 (13.1) –
Follow-up 103.0 (12.1) 105.7 (17.3) 104.8 (12.4) 0.402 104.5 (14.2) –
Change 1.3 (6.8) 0.2 (6.4) 1.7 (6.7) 0.391 0.8 (6.7) .128
95% CI 0.6 to 3.2 2.0 to 1.5 0.4 to 3.8 – 0.2 to 1.9 –
SBP (mmHg)
Baseline 136.6 (15.1) 141.5 (18.7) 140.0 (15.9) 0.278 139.4 (16.7) –
Follow-up 144.2 (18.6) 137.7 (14.9) 142.4 (14.7) 0.092 141.3 (16.4) –
Change 7.6 (14.9) 3.8 (16.2) 2.4 (17.2) 0.004 1.9 (16.7) .156
95% CI 3.6 to 11.7 8.0 to 0.4 2.8 to 7.5 – 0.7 to 4.5 –
DBP (mmHg)
Baseline 88.6 (9.5) 93.9 (12.8) 92.6 (9.9) 0.026 91.7 (11.1) –
Follow-up 92.9 (10.6) 89.0 (8.9) 91.8 (9.8) 0.103 91.2 (9.9) –
Change 4.3 (9.6) 4.9 (11.7) 0.8 (12.1) 0.003 0.5 (11.7) .570
95% CI 1.7 to 6.9 8.0 to 1.8 4.5 to 2.8 – 2.4 to 1.3 –
Total-C
Baseline 5.6 (1.0) 5.6 (1.3) 5.5 (1.0) 0.963 5.5 (1.1) –
Follow-up 5.8 (0.9) 5.3 (1.0) 5.4 (1.1) 0.830 5.5 (1.1) –
Change 0.2 (1.03) 0.3 (1.3) 0.1 (1.0) 0.029 0.0 (1.1) .666
95% CI 0.0 to 0.4 0.6 to 0.1 0.3 to 0.2 – 0.2 to 0.1 –
LDL-C
Baseline 3.26 (0.83) 3.20 (0.99) 3.27 (0.88) 0.841 3.24 (0.90) –
Follow-up 3.31 (0.78) 2.94 (0.85) 3.23 (0.94) 0.117 3.15 (0.86) –
Change 0.05 (0.60) 0.26 (0.88) 0.04 (0.84) 0.031 0.09 (0.79) .153
95% CI 0.12 to 0.22 0.50 to 0.03 0.31 to 0.22 – 0.22 to 0.03 –
HDL-C
Baseline 1.57 (0.46) 1.52 (0.36) 1.41 (0.34) 0.149 1.51 (0.39) –
Follow-up 1.42 (0.34) 1.36 (0.40) 1.29 (0.34) 0.262 1.36 (0.39) –
Change 0.15 (0.24) 0.16 (0.33) 0.12 (0.19) 0.966 0.15 (0.26) <.001
95% CI 0.22 to 0.09 0.24 to 0.07 0.19 to 0.07 – 0.19 to 0.11 –
TG
Baseline 1.72 (1.11) 2.14 (2.51) 2.03 (1.82) 0.498 1.96 (1.92) –
Follow-up 1.75 (1.04) 1.72 (0.96) 1.88 (2.86) 0.882 1.77 (1.72) –
Change 0.03 (1.04) 0.42 (2.45) 0.15 (1.49) 0.612 0.19 (1.80) .190
95% CI 0.26 to 0.31 1.07 to 0.22 0.60 to 0.31 – 0.47 to 0.09 –
Glucose
Baseline 5.5 (0.6) 5.7 (0.6) 5.6 (0.5) 0.123 5.6 (0.6) –
Follow-up 5.9 (0.8) 5.8 (0.8) 5.9 (0.7) 0.863 5.9 (0.8) –
Change 0.4 (0.6) 0.1 (0.7) 0.3 (0.5) 0.116 0.3 (0.6) <.001
95% CI 0.2 to 0.5 0.1 to 0.3 0.1 to 0.4 – 0.1 to 0.3 –
Data are means (SD).
ap Values are for testing equality between groups.
bp Values are for testing paired difference.
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; Total-C: total cholesterol
in mmol/L; LDL-C: low-density cholesterol in mmol/L; HDL-C: high-density cholesterol in mmol/L; TG: triglycerides in mmol/L, glu-
cose in mmol/L.
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Groups 2 and 3 during follow-up but in contrast
increased in the Group 1. Only in Group 2 was the
change statistically significant. Risk scores reduction
remained significant even when analyses were limited
to participants receiving no cardio-metabolic medica-
tion. The differences in changes in the CVD risk score
(p¼ .011) and in the Score risk chart (p¼ .001) between
the groups were statistically significant.
Discussion
A considerable proportion of those screened failed to
continue. In terms of the risk factors, the dropouts did
not differ from those participating in the study at
baseline. However, lifestyle factors between these two
groups did differ at baseline. Obviously, due to higher
rates of smoking, the dropouts had higher CVD risk
score, but this should not adversely influence the over-
all findings; indeed, it could even potentially
strengthen them. All study participants comprised a
uniformly high CVD risk group, attitudes towards ele-
vated CVD risk varied widely. Awareness of the risk
was insufficient to motivate all subjects to participate
in risk factor control visits. More than one third of the
participants had participated in no risk factor control
visit between baseline and follow-up visits whereas,
almost two-thirds spontaneously sought risk factors
monitoring during follow-up at either local health care
centres or at occupational health care. One feature
that distinguished the participants from one another
was a positive family history of CVD. A positive family
history was more than two times as common among
Table 3. Lifestyle characteristics at baseline and at 5-year follow-up grouped according to CVD risk control
visits.
CVD risk control visits during follow-up
No control Health centre Occupational care All
n¼ 55 n¼ 59 n¼ 45 p Valuea n¼ 159 p Valueb
Smoking, %
Baseline 63.6 50.8 51.1 0.318 55.3 –
Follow-up 50.9 37.3 40.0 0.309 42.8 –
Change –12.7 –13.5 –11.1 0.738 –12.5 <.001
95% CI 23.9 to 0.8 23.4 to 3.1 24.8 to 3.5 – 19.2 to 5.7 –
PA 90min/wk, %
Baseline 36.4 22.0 28.9 0.241 28.9 –
Follow-up 60.0 55.9 53.3 0.792 56.6 –
Change 23.6 33.9 24.4 0.859 27.7 <.001
95% CI 9.5 to 36.2 18.9 to 46.6 4.7 to 41.6 – 18.6 to 36.0 –
Users of soft fat, %
Baseline 21.8 22.0 11.1 0.277 18.9 –
Follow-up 72.7 84.7 73.3 0.246 77.4 –
Change 50.9 62.7 62.2 0.270 58.5 <.001
95% CI 35.5 to 62.3 46.6 to 73.6 45.5 to 73.9 – 49.7 to 65.5 –
PA: physical activity.
ap Values are for testing equality between groups.
bp Values are for testing paired difference.
Table 4. Risk scores at baseline and at 5-year-follow-up grouped according to CVD risk control
visits.
CVD risk control visits during follow-up
No control Primary care Occupational care All
n¼ 55 n¼ 59 n¼ 45 p Valuea n¼ 159 p Valueb
CVD risk score
Baseline 6.0 (1.7) 6.1 (1.7) 6.0 (1.4) 0.898 6.1 (1.6) –
Follow-up 5.9 (2.2) 4.8 (2.3) 5.4 (2.2) 0.027 5.4 (2.3) –
Change 0.1 (1.7) 1.3 (2.1) 0.6 (2.6) 0.011 0.7 (2.2) <.001
95% CI 0.5 to 0.4 1.9 to 0.8 1.4 to 0.1 – 1.1 to 0.4 –
Score Chart
Baseline 4.7 (1.7) 5.1 (2.2) 4.8 (2.2) 0.594 4.9 (2.1) –
Follow-up 5.2 (2.3) 4.0 (1.9) 4.3 (2.1) 0.010 4.5 (2.2) –
Change 0.5 (2.1) 1.1 (1.9) 0.5 (2.7) 0.001 0.4 (2.3) .060
95% CI 0.1 to 1.1 1.6to 0.6 1.3 to 0.3 – 0.7 to 0.02 –
Data are means (SD).
ap Values are for testing equality between groups.
bp Values are for testing paired difference.
CVD risk score: a modified version of the North Karelia project risk tool; Score Chart: CVD risk extrapolated to age
60 by Score European Low Risk Chart.
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the participants who searched for risk factor monitor-
ing during follow-up. According to the Health Belief
Model, perceived susceptibility encourages to health-
protective behaviours.[15] The literature has assessed
association between a positive family history of CVD
and health behaviour on large scale.[16–18] Surveys
comparing adults without CVD across two categories,
with and without a family history of CVD, have found
that those with such a family history were more likely
to contact with clinicians [19] and to follow clinicians’
recommendations to change their lifestyles.[20] From
data on 186,000 users of the Heart Age calculator
(www.heartage.me), investigators found that aware-
ness of cholesterol and blood pressure levels was
greater in those with a family history of CVD, but their
healthy lifestyle behaviours were no different.[21] We
found that control visits with health care providers led
to favourable changes in lifestyles factors and lower
CVD risk scores. In addition, several cardio-metabolic
risk factors showed improvement. The decrease in dia-
stolic blood pressure and in low-density cholesterol
level was statistically significant among those who
continued visits in their primary health care centre.
Also, the changes in lifestyle factors and reduction in
CVD risk scores were greater in the group visiting their
primary health care centre. However, evaluations of
the CVD risk score must take into account the fact
that this group also benefit from more active treat-
ment, as they received more cardio-protective medica-
tions than did those who received treatment at the
occupational health care. However, the lifestyle
changes alone significantly decreased the CVD risk
score and the Score Chart among men who were fol-
lowed up within the primary health care and received
no cardio-protective medication. The initial baseline
risk assessment and health counselling sessions took
place in primary health care centres, so nurses and
physicians in these centres were likely better prepared
to discuss with these participants. This may partly
explain the more favourable results achieved in the
primary health care centres than in occupational care.
Despite self-reported improvements in all lifestyle fac-
tors assessed, the men who were not followed up
showed no improvement in any cardio-metabolic risk
factors assessed or in CVD risk scores and even
showed an increase in their Score Risk Chart during
follow-up. The results of annual surveys, of health
behaviour among Finnish adult show that the con-
sumption of unsaturated fat among Finnish men was
64% in 2006 and 60% in 2011, smoking prevalence
was 24% in 2006 and 22% in 2011, and the propor-
tional level of physical activity was 63% in 2006 and
67% in 2011.[22,23] Among the study participants,
despite some minor consumption of unsaturated fat
at baseline, their use exceeded that of the general
male population at follow-up, and starting from a
much lower level of physical activity at baseline, the
study participants almost reached the level of the
general male population at follow-up. Smoking preva-
lence was higher among the study population than
among the general male population, but the
decrease was distinct. The main objective of occupa-
tional health care in Finland is to prevent work-
related illnesses. To this end, employers can offer pri-
mary care and other health care services to their
employees, but additional costs limit this possibility
in practice. The fact that the public primary care pro-
vides primary care for all may at least partly explain
why a large number of the participants were fol-
lowed up in primary health care, a fact that limits
the comparability of the results in our study between
the primary health care and occupational health care.
The main weakness of the present study was the
relatively small number of men who took part in the
final study visit. Also, the observational method of
the study may be a weakness, but randomisation of
these high-risk men would have posed ethical issues.
In the absence of a control group, we compared data
from the present study to data from surveys of the
National Institute for Health and Welfare.[22,23] The
strength of study includes the natural course of the
follow-up. All participants underwent the same risk
assessment and received the same health counselling
during baseline visits; thereafter, during the follow-
up, their health behaviour including risk factor moni-
toring visits was based on their own choices. Those
who with interest and willingness manage their risk
factors benefit most.
Conclusions
Men at high risk of CVD and who, after receiving
health counselling, continued to discuss their risk
with health care providers, based on their own deter-
mination of their need for visits, experienced a sus-
tained reduction in CVD risk. Furthermore, our
findings show that a positive family history of CVD
can contribute to healthier behaviour in this high-risk
middle-aged male population. Our findings support
to continue CVD risk evaluation and health counsel-
ling of high-risk middle-aged men. One future chal-
lenge is to encourage as many as possible of those
who were satisfied with self-care to participate in risk
monitoring visits. Health care systems also face the
challenge of providing long-term care for all at
high risk.
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